Anatara Lifesciences to launch First-of-its-kind Decentralized Clinical Trial in Australia
Clinical Trials | News | 1 Comment | 30 Sep, 2021
ObvioHealth, a global Virtual Research Organization (VRO), is set to launch a first-of-its-kind clinical trial in A...Read more
UK-based Futura Medical with OCT Clinical to run FM71 study in Eastern Europe, US
Clinical Trials | News | 1 Comment | 23 Sep, 2021
Futura Medical, a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transde...Read more
UK Medical Research Council (MRC) grants £1.5 M to investigate Alzheimer’s genetics
Clinical Trials | News | 1 Comment | 13 Sep, 2021
A £1.5 million grant from the UK's Medical Research Council (MRC) will support new research examining changes in h...Read more
China completes largest ever dry eye disease clinical trial
Clinical Trials | News | 1 Comment | 19 Aug, 2021
Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...Read more
APAC sponsors/CROs inclination to innovative and optimized DCT model trial designs
Clinical Trials | Opinion | By Hithaishi C Bhaksar | 0 Comment | 05 Aug, 2021
Clinical trials in a drug development process often face multiple hurdles around patient recruitment and management resu...Read more
Longer-interval of Pfizer vaccine dose boosts antibody levels: Study
Clinical Trials | News | 0 Comment | 23 Jul, 2021
Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...Read more
Nichi Glucan progresses to clinical studies in autism spectrum disorder
Clinical Trials | Opinion | 0 Comment | 28 Jun, 2021
Beneficial effects in autism spectrum disorders of the Japanese food supplement Nichi-Glucan (www.nichiglucan.com), a bi...Read more
eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics
Clinical Trials | News | 0 Comment | 23 Jun, 2021
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...Read more
Medidata extends a secure platform for Decentralization of Clinical Trials (DCT)
Clinical Trials | News | 0 Comment | 16 Jun, 2021
Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (D...Read more
Korea's IVI to develop adaptive Ph 1b/2a schistosomiasis vaccine trial
Clinical Trials | News | 0 Comment | 03 Jun, 2021
The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...Read more
Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment
Clinical Trials | News | 0 Comment | 05 May, 2021
Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammatio...Read more
China explores new mode of pharmaceutical R&D
Clinical Trials | News | 0 Comment | 03 May, 2021
Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...Read more
Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan
Clinical Trials | News | 0 Comment | 21 Apr, 2021
FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...Read more
TrialWire launches StudyBoost, the Clinical trial insurance plan
Clinical Trials | News | 1 Comment | 23 Mar, 2021
TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...Read more
UK conducts innovative COVID-19 trials with deliberate volunteered infection
Clinical Trials | News | 0 Comment | 02 Mar, 2021
United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...Read more
Panthera to evaluate AstraZeneca’s AZD7442 for the potential prevention of COVID-19
Clinical Trials | News | 0 Comment | 30 Dec, 2020
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...Read more
Tychan to begin Ph 3 trial for mAb TY027 against COVID-19
Clinical Trials | News | 0 Comment | 14 Dec, 2020
In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...Read more
Contract for innovative delivery system for COVID-19 vaccine
Clinical Trials | News | 0 Comment | 16 Nov, 2020
Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...Read more